Using computational models, the researchers studied how the brain's reward-learning system functions in those with depression, especially among individuals experiencing anhedonia, the inability to ...

Add Yahoo as a preferred source to see more of our stories on Google. If depression affects a quarter of the population and has been studied for centuries, why is it still so difficult to treat? New ...

On its face, depression seems like something we are all familiar with. You, or someone you know, are feeling down or “blue.” You’re dealing with a bout of sadness more prolonged than you’d like. But ...

For decades, depression treatment has focused almost entirely on the brain, with drugs designed to tweak neurotransmitters like serotonin and dopamine. Now a wave of research is pointing to an ...

Major depressive disorder (MDD) affects about 10.4 percent of adults in one year and 20.6 percent over a lifetime (Hasin, 2018). Unfortunately, by themselves, psychotherapy and antidepressants only ...

The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression. Spravato is made ...

Depression is a leading cause of disability worldwide, affecting millions of lives and posing serious challenges for healthcare systems. While existing antidepressants help many, a significant ...

As the conversation around mental health disorders like depression becomes increasingly normalized, it can also blur the lines between situational feelings of stress, anxiety, and dejection and ...